159 related articles for article (PubMed ID: 28450653)
1. Prediction of Wound Healing in Diabetic Foot Ulcers: an Observational Study in Tertiary Hospital in Indonesia.
Soewondo P; Suyono S; Sastrosuwignyo MK; Harahap AR; Sutrisna B; Makmun LH
Acta Med Indones; 2017 Jan; 49(1):41-51. PubMed ID: 28450653
[TBL] [Abstract][Full Text] [Related]
2. Comparison of characteristics and healing course of diabetic foot ulcers by etiological classification: neuropathic, ischemic, and neuro-ischemic type.
Yotsu RR; Pham NM; Oe M; Nagase T; Sanada H; Hara H; Fukuda S; Fujitani J; Yamamoto-Honda R; Kajio H; Noda M; Tamaki T
J Diabetes Complications; 2014; 28(4):528-35. PubMed ID: 24846054
[TBL] [Abstract][Full Text] [Related]
3. Low-level laser therapy as an adjunct to conventional therapy in the treatment of diabetic foot ulcers.
Mathur RK; Sahu K; Saraf S; Patheja P; Khan F; Gupta PK
Lasers Med Sci; 2017 Feb; 32(2):275-282. PubMed ID: 27896528
[TBL] [Abstract][Full Text] [Related]
4. Transcutaneous oxygen pressure measurement in diabetic foot ulcers: mean values and cut-point for wound healing.
Yang C; Weng H; Chen L; Yang H; Luo G; Mai L; Jin G; Yan L
J Wound Ostomy Continence Nurs; 2013; 40(6):585-9. PubMed ID: 24202221
[TBL] [Abstract][Full Text] [Related]
5. Correlation between initial serum 25-hydroxyvitamin D and granulation growth in diabetic foot ulcers.
Yunir E; Adesta FEA; Rizka A; Tarigan TJE
J Wound Care; 2024 Jun; 33(Sup6a):clii-clix. PubMed ID: 38850545
[TBL] [Abstract][Full Text] [Related]
6. Osteoprotegerin and 25-hydroxy vitamin D levels in patients with diabetic foot.
Çağlar S; Çağlar A; Pilten S; Albay C; Beytemur O; Sarı H
Eklem Hastalik Cerrahisi; 2018 Dec; 29(3):170-5. PubMed ID: 30376802
[TBL] [Abstract][Full Text] [Related]
7. Plasma osteoprotegerin concentrations in type 2 diabetic patients and its association with neuropathy.
Terekeci HM; Senol MG; Top C; Sahan B; Celik S; Sayan O; Kucukardali Y; Ipcioglu O; Cagiltay E; Oktenli C; Ozata M
Exp Clin Endocrinol Diabetes; 2009 Mar; 117(3):119-23. PubMed ID: 19053023
[TBL] [Abstract][Full Text] [Related]
8. The characterization of a full-thickness excision open foot wound model in n5-streptozotocin (STZ)-induced type 2 diabetic rats that mimics diabetic foot ulcer in terms of reduced blood circulation, higher C-reactive protein, elevated inflammation, and reduced cell proliferation.
Yu CO; Leung KS; Fung KP; Lam FF; Ng ES; Lau KM; Chow SK; Cheung WH
Exp Anim; 2017 Aug; 66(3):259-269. PubMed ID: 28413186
[TBL] [Abstract][Full Text] [Related]
9. A Prospective, Randomized, Blinded, Controlled Trial Comparing Transdermal Continuous Oxygen Delivery to Moist Wound Therapy for the Treatment of Diabetic Foot Ulcers.
Driver VR; Reyzelman A; Kawalec J; French M
Ostomy Wound Manage; 2017 Apr; 63(4):12-28. PubMed ID: 28448266
[TBL] [Abstract][Full Text] [Related]
10. ENA-78 Is a Novel Predictor of Wound Healing in Patients with Diabetic Foot Ulcers.
Li JY; Wang ZJ; Deng AP; Li YM
J Diabetes Res; 2019; 2019():2695436. PubMed ID: 30775384
[TBL] [Abstract][Full Text] [Related]
11. Plasma Heat Shock Proteins (HSPs) 70 and 47 levels in diabetic foot and its possible correlation with clinical variables in a North Indian Tertiary care hospital.
Zubair M; Ahmad J
Diabetes Metab Syndr; 2015; 9(4):237-43. PubMed ID: 25784639
[TBL] [Abstract][Full Text] [Related]
12. An Automatic Assessment System of Diabetic Foot Ulcers Based on Wound Area Determination, Color Segmentation, and Healing Score Evaluation.
Wang L; Pedersen PC; Strong DM; Tulu B; Agu E; Ignotz R; He Q
J Diabetes Sci Technol; 2015 Aug; 10(2):421-8. PubMed ID: 26253144
[TBL] [Abstract][Full Text] [Related]
13. Diabetic foot disease: impact of ulcer location on ulcer healing.
Pickwell KM; Siersma VD; Kars M; Holstein PE; Schaper NC;
Diabetes Metab Res Rev; 2013 Jul; 29(5):377-83. PubMed ID: 23390115
[TBL] [Abstract][Full Text] [Related]
14. Combined with dynamic serum proteomics and clinical follow-up to screen the serum proteins to promote the healing of diabetic foot ulcer.
Zhao F; Xie L; Weng Z; Huang Y; Zheng L; Yan S; Shen X
Endocrine; 2024 May; 84(2):365-379. PubMed ID: 37938414
[TBL] [Abstract][Full Text] [Related]
15. Advanced biological therapies for diabetic foot ulcers.
Kirsner RS; Warriner R; Michela M; Stasik L; Freeman K
Arch Dermatol; 2010 Aug; 146(8):857-62. PubMed ID: 20713816
[TBL] [Abstract][Full Text] [Related]
16. Treatment of chronic plantar ulcer of the diabetic foot using an irremovable windowed fibreglass cast boot: prospective study of 177 patients.
Ha Van G; Michaux C; Parquet H; Bourron O; Pradat-Diehl P; Hartemann A
Diabetes Metab Res Rev; 2015 Oct; 31(7):691-8. PubMed ID: 25941091
[TBL] [Abstract][Full Text] [Related]
17. Does Baseline Hemoglobin A
Vella L; Gatt A; Formosa C
J Am Podiatr Med Assoc; 2017 Jul; 107(4):272-279. PubMed ID: 28880596
[TBL] [Abstract][Full Text] [Related]
18. The effects of ulcer size on the wound radius reductions and healing times in neuropathic diabetic foot ulcers.
Zimny S; Schatz H; Pfohl M
Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):191-4. PubMed ID: 15127323
[TBL] [Abstract][Full Text] [Related]
19. Conservative surgical approach versus non-surgical management for diabetic neuropathic foot ulcers: a randomized trial.
Piaggesi A; Schipani E; Campi F; Romanelli M; Baccetti F; Arvia C; Navalesi R
Diabet Med; 1998 May; 15(5):412-7. PubMed ID: 9609364
[TBL] [Abstract][Full Text] [Related]
20. Below-knee arterial calcification in type 2 diabetes: association with receptor activator of nuclear factor κB ligand, osteoprotegerin, and neuropathy.
Bourron O; Aubert CE; Liabeuf S; Cluzel P; Lajat-Kiss F; Dadon M; Komajda M; Mentaverri R; Brazier M; Pierucci A; Morel F; Jacqueminet S; Massy ZA; Hartemann A
J Clin Endocrinol Metab; 2014 Nov; 99(11):4250-8. PubMed ID: 25013993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
